Back to Atlases main

Breast Cancer Atlas

Visit the Gray BRCA Pre-cancer Atlas View Narrated Data View Curated Data View Automated Data

Publications

Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

Qualification of a multiplexed tissue imaging assay and detection of novel patterns of HER2 heterogeneity in breast cancer

Guerriero JL, Lin JR, Pastorello RG, Du Z, Chen YA, Townsend M, Shimada K, Hughes ME ... Santagata S (2024).
npj Breast Cancer, 10(2). https://doi.org/10.1038/s41523-023-00605-3
A human breast atlas integrating single-cell proteomics and transcriptomics.

A human breast atlas integrating single-cell proteomics and transcriptomics.

Gray GK, Li CM-C, Rosenbluth JM, Selfors LM, Girnius N, Lin J-R, Schackmann RCJ, Goh WL, Moore K,...Brugge JS. (2022).
Developmental Cell, 57(22), 1400-1420. https://doi.org/10.1016/j.devcel.2022.05.003
Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer.

Targeting immunosuppressive macrophages overcomes PARP inhibitor resistance in BRCA1-associated triple-negative breast cancer.

Mehta AK, Cheney EM, Hartl CA, Pantelidou C, Oliwa M, Castrillon JA, Lin, J-R,... Guerriero, J. (2021).
Nature Cancer, 2(1), 66–82. https://doi.org/10.1038/s43018-020-00148-7
AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

AKT and EZH2 inhibitors kill TNBCs by hijacking mechanisms of involution

Schade A, Perurena N, Yang Y, Rodriguez CL, Krishnan A, Loi P, Mastellone GM, Pilla NF,... Cichowski K. (2024).
Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer.

Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer.

Keenan TE, Li T, Vallius T, Guerriero JL, Tayob N, Kochupurakkal B, Davis J, Pastorello R,... Tolaney SM. (2021).
Clinical Cancer Research, 2(1), 66-82. https://doi.org/10.1158/1078-0432.CCR-20-3089

Narrated Minerva Stories

Narrated stories use multi-step narrations and annotations to walk a viewer through key features of the data. Narrated stories distill the multidisciplinary knowledge encompassed by each dataset into a single product that grounds the scientific analyses in the underlying data and metadata. Click the Minerva story icon for an interactive view of the full-resolution images.

Data image
Temporal and spatial topography of cell proliferation in cancer
Data image
BRCA wild-type TNBC vs BRCA1-associated TNBC
Data image
Clinical Benefit - Cisplatin Biopsy
Data image
Clinical Benefit - Cis Wee1i Biopsy
Data image
No Clinical Benefit - Cis Wee1i Biopsy
Data image
No Clinical Benefit - Cisplatin Biopsy
Data image
Temporal and spatial topography of cell proliferation in cancer

Curated Minerva Stories

Curated stories provide access to images that have undergone a quality control step to remove failed markers, ensure appropriate channel intensity settings, and provide metadata about the underlying sample and image. Click the Minerva story icon for an interactive view of the full-resolution images.

Data image
TMA of 16 Breast Cancer Samples and Normal Tissue (BC03)
Data image
CK1 (BRCA wildtype)
Data image
CK2 (BRCA wildtype)
Data image
CK3_R (BRCA wildtype)
Data image
CK4_P (BRCA wildtype)
Data image
CK4_R (BRCA wildtype)
Data image
CK5 (BRCA wildtype)
Data image
CK6 (BRCA wildtype)
Data image
CK7 (BRCA wildtype)
Data image
CK8 (BRCA wildtype)
Data image
CK9 (BRCA wildtype)
Data image
CK10 (BRCA wildtype)
Data image
CK11 (BRCA wildtype)
Data image
CK12 (BRCA wildtype)
Data image
CK13 (BRCA wildtype)
Data image
CK14 (BRCA wildtype)
Data image
CK15 (BRCA wildtype)
Data image
CK16 (BRCA wildtype)
Data image
CK17_M (BRCA wildtype)
Data image
CK18_P (BRCA wildtype)
Data image
CK19_BCC (BRCA wildtype)
Data image
CK19_BCC2 (BRCA wildtype)
Data image
CK20 (BRCA wildtype)
Data image
CK21 (BRCA wildtype)
Data image
CK22 (BRCA wildtype)
Data image
CK23 (BRCA wildtype)
Data image
CK24 (BRCA wildtype)
Data image
CK25_R (BRCA wildtype)
Data image
CK26 (BRCA wildtype)
Data image
W2BC_3 (BRCA wildtype)
Data image
W8B_4 (BRCA wildtype)
Data image
K1 (BRCA mutant)
Data image
K2 (BRCA mutant)
Data image
K3 (BRCA mutant)
Data image
K4 (BRCA mutant)
Data image
K5 (BRCA mutant)
Data image
K6 (BRCA mutant)
Data image
K7 (BRCA mutant)
Data image
K8 (BRCA mutant)
Data image
K9 (BRCA mutant)
Data image
K10 (BRCA mutant)
Data image
K11 (BRCA mutant)
Data image
K12 (BRCA mutant)
Data image
K13 (BRCA mutant)
Data image
K14 (BRCA mutant)
Data image
K15 (BRCA mutant)
Data image
K16 (BRCA mutant)
Data image
K17 (BRCA mutant)
Data image
K18 (BRCA mutant)
Data image
K19 (BRCA mutant)
Data image
K20 (BRCA mutant)
Data image
K21 (BRCA mutant)
Data image
K22 (BRCA mutant)
Data image
K23 (BRCA mutant)
Data image
K24 (BRCA mutant)
Data image
K26 (BRCA mutant)
Data image
K27 (BRCA mutant)

Automated Minerva Stories

Automated stories provide basic image viewing with automatic rendering settings, enabling rapid, lightweight sharing of highly multiplexed images, without download. Click the Minerva story icon for an interactive view of the full-resolution images.

Data image
BRCA1-associated-9
Data image
BRCA1-associated TNBC 8
Data image
BRCA1-associated TNBC 7
Data image
BRCA1-associated TNBC 6
Data image
BRCA1-associated TNBC 5
Data image
BRCA1-associated TNBC 4
Data image
BRCA1-associated TNBC 3
Data image
BRCA1-associated TNBC 2
Data image
BRCA1-associated-10
Data image
BRCA1-associated TNBC 1
Data image
BRCA wild-type TNBC (BRCA-WT-6)
Data image
BRCA wild-type TNBC (BRCA-WT-5)
Data image
BRCA wild-type TNBC (BRCA-WT-4)
Data image
BRCA wild-type TNBC (BRCA-WT-3)
Data image
BRCA wild-type TNBC (BRCA-WT-2)
Data image
BRCA wild-type TNBC (BRCA-WT-1)

Funding

This research is funded by the Gray Foundation Basser Initiative, Ludwig Cancer Research, and the National Cancer Institute (NCI U54 CA225088).